BACKGROUND Beta-2 agonists such as salbutamol are used, not only by asthmatic athletes to prevent exercise induced asthma, but also by non-asthmatic athletes as a potentially ergogenic agent. We have ...
Background The impact of delays to diagnosis for individuals presenting with chronic breathlessness is unknown. We ...
Background The Quality of Life-Bronchiectasis (QOL-B), a self-administered, patient-reported outcome measure assessing symptoms, functioning and health-related quality of life for patients with ...
Hunter Medical Research Institute, Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, NSW, Australia Correspondence to: Dr P G Gibson Hunter Medical Research Institute, ...
1 Respiratory Research Unit, Department of Respiratory Medicine, Waikato Hospital, New Zealand 2 Department of Anaesthesia, Waikato Hospital, New Zealand 3 Department of General Medicine, Waikato ...
1 Sir James Spence Institute of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK 2 Department of Radiology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK 3 Department of ...
1 Cancer Research Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK 2 Division of Epidemiology and Public Health, University of ...
1 Department of Pathology, University of British Columbia, Vancouver, BC, Canada 2 Department of Medicine, University of British Columbia and Head, Respiratory Division, St Paul’s Hospital, Vancouver, ...
1 Division of Paediatric Respirology and Department of Physiotherapy, Cystic Fibrosis Clinic, BC Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada 2 Division ...
Background: Over 38 000 new cases of lung cancer occur each year in the UK. Most are diagnosed after initial presentation to primary care, but the relative importance of the various clinical features ...
Background: Caffeine is known to inhibit phosphodiesterases, to mobilise intracellular calcium, and to act as an antagonist at adenosine receptors, all of which can potentially alter nitric oxide (NO) ...
3 Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Correspondence to: Dr C M Chu Division of Respiratory Medicine, Department of Medicine and Geriatrics, United ...